Cargando…
Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution
BACKGROUND: Colorectal cancer liver metastases (CRCLM) are associated with a poor prognosis, reflected by a five-year survival rate of 14%. Anti-angiogenic therapy through anti-VEGF antibody administration is one of the limited therapies available. However, only a subgroup of metastases uses sprouti...
Autores principales: | Fleischer, Johannes Robert, Schmitt, Alexandra Maria, Haas, Gwendolyn, Xu, Xingbo, Zeisberg, Elisabeth Maria, Bohnenberger, Hanibal, Küffer, Stefan, Teuwen, Laure-Anne, Karras, Philipp Johannes, Beißbarth, Tim, Bleckmann, Annalen, Planque, Mélanie, Fendt, Sarah-Maria, Vermeulen, Peter, Ghadimi, Michael, Kalucka, Joanna, De Oliveira, Tiago, Conradi, Lena-Christin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872436/ https://www.ncbi.nlm.nih.gov/pubmed/36691028 http://dx.doi.org/10.1186/s12943-023-01713-1 |
Ejemplares similares
-
Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo
por: De Oliveira, Tiago, et al.
Publicado: (2021) -
High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome
por: Menck, Kerstin, et al.
Publicado: (2022) -
The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer
por: Rühlmann, Felix, et al.
Publicado: (2017) -
The prognostic capacities of CBP and p300 in locally advanced rectal cancer
por: Rühlmann, Felix, et al.
Publicado: (2019) -
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
por: Conradi, Lena-Christin, et al.
Publicado: (2019)